NEUREN PHARMACEUTICALS LIMITED - Announcements

2.38%

$17.46

Market Cap $2.219B

Healthcare Biotechnology

Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing... Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing therapies for neurodevelopmental disorders. The Company is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The Company has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run. Latest:...

Announcements

Filter Results

All Price Sensitive Only

NEU	Initial Director's Interest Notice		15/12/09	94.33KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		04/12/09	54.59KB	Share
NEU	Appendix 3B		04/12/09	86.43KB	Share
NEU	Notice of Special Shareholders Meeting		04/12/09	179.51KB	Share
NEU	Dr John Holaday joins Neuren Board		25/11/09	26.85KB	Share
NEU	Appendix 3B (notes)		18/11/09	95.09KB	Share
NEU	Appendix 3B (options)		18/11/09	88.79KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		18/11/09	57.22KB	Share
NEU	Neuren Arranges up to AU$7.8m in New Funding	PRICE SENSITIVE	18/11/09	30.56KB	Share
NEU	Appendix 3B (shares)		18/11/09	87.68KB	Share
NEU	Reinstatement to Official Quotation	PRICE SENSITIVE	18/11/09	22.19KB	Share
NEU	Suspension from Official Quotation	PRICE SENSITIVE	16/11/09	83.33KB	Share
NEU	Trading Halt	PRICE SENSITIVE	12/11/09	84.68KB	Share
NEU	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/09	138.72KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		25/09/09	54.61KB	Share
NEU	Appendix 3B		25/09/09	85.85KB	Share
NEU	Reponse to Price Query	PRICE SENSITIVE	22/09/09	120.46KB	Share
NEU	Half Year Report and Accounts	PRICE SENSITIVE	31/08/09	353.28KB	Share
NEU	Appendix 3B		14/08/09	85.81KB	Share
NEU	Neuren raises NZ$1 million through SPP		14/08/09	23.62KB	Share
NEU	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/09	137.94KB	Share
NEU	Neuren SPP section 708A notice		22/07/09	55.01KB	Share
NEU	SPP NZ Certification		21/07/09	68.11KB	Share
NEU	Neuren NNZ-2566 Development Overview	PRICE SENSITIVE	20/07/09	99.66KB	Share
NEU	Neuren Share Purchase Plan		20/07/09	111.7KB	Share
NEU	Neuren Chairmans SPP Letter		20/07/09	100.85KB	Share
NEU	SPP terms update		15/07/09	48.26KB	Share
NEU	Neuren Share Purchase Plan	PRICE SENSITIVE	10/07/09	53.24KB	Share
NEU	Ceasing to be a substantial holder		02/07/09	49.01KB	Share
NEU	Neuren obtains further US$14m US Army funding	PRICE SENSITIVE	01/07/09	41.76KB	Share
NEU	Results of Meeting		28/05/09	36.24KB	Share
NEU	Presentation to AGM		28/05/09	209.97KB	Share
NEU	Chairman's Address to Shareholders		28/05/09	26.36KB	Share
NEU	Response to ASX Query - Appendix 4C	PRICE SENSITIVE	15/05/09	100.17KB	Share
NEU	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/09	136.62KB	Share
NEU	Notice of Annual General Meeting/Proxy Form		28/04/09	132.68KB	Share
NEU	Neuren Progresses Cancer Program	PRICE SENSITIVE	22/04/09	30.31KB	Share
NEU	Trading Halt	PRICE SENSITIVE	21/04/09	77.51KB	Share
NEU	Response to ASX Price Query	PRICE SENSITIVE	17/04/09	235.22KB	Share
NEU	Trading Halt	PRICE SENSITIVE	16/04/09	196.75KB	Share
NEU	Lapse of unquoted options		01/04/09	42.62KB	Share
NEU	Annual Report to shareholders		31/03/09	382.39KB	Share
NEU	Final Director's Interest Notice		30/03/09	23.45KB	Share
NEU	Preliminary Final Report	PRICE SENSITIVE	27/02/09	165.2KB	Share
NEU	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/09	136.05KB	Share
NEU	Neuren Strategy Update	PRICE SENSITIVE	21/01/09	31.29KB	Share
NEU	Respone to ASX price query	PRICE SENSITIVE	20/01/09	241.74KB	Share
NEU	Trading Halt	PRICE SENSITIVE	19/01/09	85.29KB	Share
NEU	Change of Director's Interest Notice		14/01/09	28.04KB	Share
NEU	Neuren Announces Glypromate Trial Preliminary Results	PRICE SENSITIVE	24/12/08	44.61KB	Share

NEUInitial Director's Interest Notice
15/12/09		94.33KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
04/12/09		54.59KB	Share
NEUAppendix 3B
04/12/09		86.43KB	Share
NEUNotice of Special Shareholders Meeting
04/12/09		179.51KB	Share
NEUDr John Holaday joins Neuren Board
25/11/09		26.85KB	Share
NEUAppendix 3B (notes)
18/11/09		95.09KB	Share
NEUAppendix 3B (options)
18/11/09		88.79KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
18/11/09		57.22KB	Share
NEUNeuren Arranges up to AU$7.8m in New Funding
18/11/09	PRICE SENSITIVE	30.56KB	Share
NEUAppendix 3B (shares)
18/11/09		87.68KB	Share
NEUReinstatement to Official Quotation
18/11/09	PRICE SENSITIVE	22.19KB	Share
NEUSuspension from Official Quotation
16/11/09	PRICE SENSITIVE	83.33KB	Share
NEUTrading Halt
12/11/09	PRICE SENSITIVE	84.68KB	Share
NEUAppendix 4C - quarterly
30/10/09	PRICE SENSITIVE	138.72KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
25/09/09		54.61KB	Share
NEUAppendix 3B
25/09/09		85.85KB	Share
NEUReponse to Price Query
22/09/09	PRICE SENSITIVE	120.46KB	Share
NEUHalf Year Report and Accounts
31/08/09	PRICE SENSITIVE	353.28KB	Share
NEUAppendix 3B
14/08/09		85.81KB	Share
NEUNeuren raises NZ$1 million through SPP
14/08/09		23.62KB	Share
NEUAppendix 4C - quarterly
31/07/09	PRICE SENSITIVE	137.94KB	Share
NEUNeuren SPP section 708A notice
22/07/09		55.01KB	Share
NEUSPP NZ Certification
21/07/09		68.11KB	Share
NEUNeuren NNZ-2566 Development Overview
20/07/09	PRICE SENSITIVE	99.66KB	Share
NEUNeuren Share Purchase Plan
20/07/09		111.7KB	Share
NEUNeuren Chairmans SPP Letter
20/07/09		100.85KB	Share
NEUSPP terms update
15/07/09		48.26KB	Share
NEUNeuren Share Purchase Plan
10/07/09	PRICE SENSITIVE	53.24KB	Share
NEUCeasing to be a substantial holder
02/07/09		49.01KB	Share
NEUNeuren obtains further US$14m US Army funding
01/07/09	PRICE SENSITIVE	41.76KB	Share
NEUResults of Meeting
28/05/09		36.24KB	Share
NEUPresentation to AGM
28/05/09		209.97KB	Share
NEUChairman's Address to Shareholders
28/05/09		26.36KB	Share
NEUResponse to ASX Query - Appendix 4C
15/05/09	PRICE SENSITIVE	100.17KB	Share
NEUAppendix 4C - quarterly
30/04/09	PRICE SENSITIVE	136.62KB	Share
NEUNotice of Annual General Meeting/Proxy Form
28/04/09		132.68KB	Share
NEUNeuren Progresses Cancer Program
22/04/09	PRICE SENSITIVE	30.31KB	Share
NEUTrading Halt
21/04/09	PRICE SENSITIVE	77.51KB	Share
NEUResponse to ASX Price Query
17/04/09	PRICE SENSITIVE	235.22KB	Share
NEUTrading Halt
16/04/09	PRICE SENSITIVE	196.75KB	Share
NEULapse of unquoted options
01/04/09		42.62KB	Share
NEUAnnual Report to shareholders
31/03/09		382.39KB	Share
NEUFinal Director's Interest Notice
30/03/09		23.45KB	Share
NEUPreliminary Final Report
27/02/09	PRICE SENSITIVE	165.2KB	Share
NEUAppendix 4C - quarterly
30/01/09	PRICE SENSITIVE	136.05KB	Share
NEUNeuren Strategy Update
21/01/09	PRICE SENSITIVE	31.29KB	Share
NEURespone to ASX price query
20/01/09	PRICE SENSITIVE	241.74KB	Share
NEUTrading Halt
19/01/09	PRICE SENSITIVE	85.29KB	Share
NEUChange of Director's Interest Notice
14/01/09		28.04KB	Share
NEUNeuren Announces Glypromate Trial Preliminary Results
24/12/08	PRICE SENSITIVE	44.61KB	Share

REFRESH

First 5 6 7 8 9

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $17.46		Change -0.425(2.38%)		Mkt cap ! $2.219B

Open	High	Low	Value	Volume
$17.93	$18.06	$17.43	$10.35M	582.3K

Buyers (Bids)

No.	Vol.	Price($)
8	147	$17.45

Sellers (Offers)

Price($)	Vol.	No.
$17.46	637	5

View Market Depth

No.	Vol.	Price($)
1	11	17.480
5	154	17.470
16	1551	17.460
5	755	17.450
4	917	17.440

Price($)	Vol.	No.
17.490	463	7
17.500	1141	20
17.510	1245	15
17.520	771	8
17.530	940	6

Last trade - 14.37pm 13/08/2025 (20 minute delay)


Last $17.39		Change -0.425 ( 2.46 %)
Open	High	Low	Volume
$17.72	$18.05	$17.39	87053
Last updated 14.57pm 13/08/2025 ?

NEU (ASX) Chart

NEUREN PHARMACEUTICALS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories